Swiss Life Asset Management Ltd Cuts Stock Holdings in Avantor, Inc. $AVTR

Swiss Life Asset Management Ltd lowered its holdings in Avantor, Inc. (NYSE:AVTR) by 69.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 32,023 shares of the company’s stock after selling 73,997 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Avantor were worth $400,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Royal Bank of Canada raised its stake in Avantor by 104.3% in the first quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock worth $3,302,000 after buying an additional 104,022 shares in the last quarter. Empowered Funds LLC boosted its position in Avantor by 40.3% during the 1st quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock valued at $286,000 after acquiring an additional 5,075 shares in the last quarter. SG Americas Securities LLC increased its holdings in shares of Avantor by 2.7% in the 2nd quarter. SG Americas Securities LLC now owns 37,078 shares of the company’s stock valued at $499,000 after acquiring an additional 979 shares during the period. Creative Planning increased its holdings in shares of Avantor by 29.5% in the 2nd quarter. Creative Planning now owns 56,016 shares of the company’s stock valued at $754,000 after acquiring an additional 12,750 shares during the period. Finally, Cetera Investment Advisers raised its position in shares of Avantor by 40.2% in the 2nd quarter. Cetera Investment Advisers now owns 40,289 shares of the company’s stock worth $542,000 after acquiring an additional 11,543 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insiders Place Their Bets

In other news, Director Gregory L. Summe purchased 100,000 shares of the company’s stock in a transaction on Thursday, February 12th. The shares were acquired at an average price of $9.40 per share, for a total transaction of $940,000.00. Following the purchase, the director owned 400,000 shares in the company, valued at $3,760,000. This trade represents a 33.33% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Sanjeev K. Mehra acquired 125,000 shares of the business’s stock in a transaction dated Tuesday, March 10th. The stock was purchased at an average cost of $8.01 per share, for a total transaction of $1,001,250.00. Following the completion of the acquisition, the director directly owned 475,000 shares of the company’s stock, valued at approximately $3,804,750. This trade represents a 35.71% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders bought 275,000 shares of company stock valued at $2,399,250. 1.20% of the stock is owned by company insiders.

Avantor Trading Down 0.7%

NYSE AVTR opened at $7.68 on Thursday. The company has a fifty day simple moving average of $9.63 and a two-hundred day simple moving average of $11.36. The stock has a market cap of $5.23 billion, a P/E ratio of -9.84, a P/E/G ratio of 3.03 and a beta of 0.97. Avantor, Inc. has a 12-month low of $7.38 and a 12-month high of $16.44. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The firm had revenue of $1.66 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the company earned $0.27 earnings per share. The business’s quarterly revenue was down 1.4% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Wall Street Analyst Weigh In

AVTR has been the topic of a number of recent research reports. Citigroup dropped their price objective on Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a research report on Thursday, February 12th. Evercore set a $10.00 target price on shares of Avantor in a report on Wednesday, February 11th. Wells Fargo & Company decreased their price target on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. TD Cowen restated a “hold” rating on shares of Avantor in a report on Thursday, February 12th. Finally, Robert W. Baird set a $11.00 price objective on shares of Avantor in a research report on Thursday, February 12th. Three research analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $11.80.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.